Table S1: List of the 646 known pathogenic genes targeted in the present study and their associated mode of inheritance. ARID: autosomal-recessive

Size: px
Start display at page:

Download "Table S1: List of the 646 known pathogenic genes targeted in the present study and their associated mode of inheritance. ARID: autosomal-recessive"

Transcription

1 Table S1: List of the 646 known pathogenic genes targeted in the present study and their associated mode of inheritance. : autosomal-recessive intellectual disability; : autosomal-dominant intellectual disability; : X-linked intellectual disability. ABAT ABCD1 ABRA ACBD6 ACSL4 ACTB ACTG1 ACY1 ADAR ADAT3 ADD3 ADK ADRA2B ADSL AGAP1 AHI1 AIMP1 AIPL1 AKT3 ALDH7A1 ALG1 ALG11 ALG12 ALG13 ALG2 ALG3 ALG6 ALG8 ALG9 AMPD2 AMT ANK3 ANKRD11 AP1S2 AP3B1 AP4B1 AP4E1 AP4M1 AP4S1 ARFGEF2 ARHGEF6 ARHGEF9 1A 1B ARL13B ARL6 ARNT2 ARSA ARX ASCL1 ASNS ASPA ASPM ASXL1 ASXL3 ATM ATP5A1 ATP6AP2 ATP6V0A2 ATP7A ATP8A2 ATR ATRX ATXN1 B3GALNT2 B3GALTL B3GNT1 B4GALT1 B9D1 B9D2 BBIP1 BBS1 BBS10 BBS12 BBS2 BBS4 BBS5 BBS7 BBS9 BCAP31 BCOR BLM BOLA3 BRAF BRD2 BRD3 BRWD3 BSCL2 BUB1B C11orf46 C12orf57 C2ORF86 C3orf58 C5orf42 C8orf41 C9orf86 CA8 CACNA1G CACNG2 CAPN10 CASC5 CASK CASP2 CBL CBS CC2D1A CC2D2A CCDC22 CCDC28B CCDC88C CCNA2 CDC6 CDH15 CDK19 CDK5RAP2 CDK6 CDKL5 CDKN1C CDT1 CECR2 CELF4 CENPJ CEP135 CEP152 CEP290 CEP41 CEP63 CEP89 CHD2 CHD7 CHMP1A CHN1 CLCN4 CLIC2 CLIP2 CLN3 CLN5 CLN6 CLN8 CNKSR1 CNKSR2 CNTN2 CNTN4 CNTNAP2 COASY COG1 COG4

2 COG5 COG6 COG7 COG8 COQ5 COX7B CRADD CRBN CREBBP CSPP1 CTCF CTNNB1 CTSD CUL4B DAG1 DARS DCHS1 DCX DDOST DDX11 DEAF1 DHCR24 DHCR7 DLG3 DLK1 DNM2 DNMT1 DNMT3A DNMT3B DOCK8 DOLK DPAGT1 DPM1 DPM2 DPM3 DYNC1H1 DYRK1A EBP EEF1B2 EFTUD2 EHMT1 EIF2B1 EIF2B2 EIF2B3 EIF2B4 EIF2B5 EIF2S3 EIF4A3 ELF2 ELOVL4 ELP2 ENOSF1 ENTPD1 EP300 EPB41L1 ERCC1 ERCC4 ERLIN2 ESCO2 EVC2 EXOC4 EXOSC3 EYA1 EZH2 FAM126A FAM58A FANCB FASN FAT4 FBXL4 FGD1 FIG4 FKRP FKTN FLNA FMN2 FMR1 FOLR1 FOXG1 FOXP1 FOXP2 FRY FTSJ1 GAD1 GALC GAMT GATAD2B GATM GCSH GDI1 GFAP GJC2 GK GLDC GLI3 GLIPR1 GMPPA GNAO1 GON4L GPC3 GPD2 GPR56 GRIA3 GRID2 GRIK2 GRIN1 GRIN2A GRIN2B GTF2I HCCS HCFC1 HDAC4 HDAC8 HEPACAM HERC2 HESX1 HEXA HIP1 HIST1H4B HIST3H3 HOXA1 HPRT1 HRAS HSD17B10 HSPD1 HUWE1 IDS IER3IP1 IGBP1 IGF1R IKBKG IL1RAPL1 INO80 INPP4A INPP5E IQSEC2 ISPD JAG1 J2 JHDM1D JMJD1C KANK1 KANSL1 KAT6A KAT6B KCNJ10 KCNK9 KCNQ2 KCNT1 KCTD13 KDM5A KDM5C KDM6A KDM6B KIAA0196 KIAA1279 KIAA2022 KIF11 KIF1A

3 KIF2A KIF5C KIF7 KIRREL3 KLF8 KLHL15 KDM2A KMT2C KMT2D KPTN KRAS L1CAM L2HGDH LAMA1 LAMC1 LAMP2 LARGE LARP7 LAS1L LIAS LIG4 LIMS1 LINS LRP2 LYRM7 MACROD2 MAGEL2 MAN1B1 MAOA MAOB MAP2K1 MAP2K2 MBD5 MBTPS2 MCPH1 MECP2 MED12 MED13L MED17 MED23 MEF2C MFSD8 MGAT2 MID1 MID2 MKKS MKL1 MKL2 MKS1 MKS1 MLC1 MOGS MPDU1 MPDZ MPI MTHFR MTOR MTR MYCN MYOCD NAA10 NAGLU NALCN NDE1 NDP NDST1 NDUFA1 NFIX NHS NID1 NIN NIPBL NLGN3 NLGN4X NLRP2 NLRP7 NPHP1 NR1I3 NRAS NRXN1 NSD1 NSDHL NSUN2 OCLN OCRL OFD1 OPHN1 ORC1 ORC4 ORC6 OSTM1 OTC PACS1 PAFAH1B1 PAK3 PARP1 PCDH19 PCNT PDE4D PDE6D PDHA1 PDHX PECR PEX1 PEX10 PEX12 PEX13 PEX14 PEX16 PEX19 PEX2 PEX26 PEX3 PEX5 PEX6 PEX7 PGAP2 PGAP3 PGK1 PGM1 PHC1 PHF21A PHF6 PHF8 PIGA PIGN PIGW PIK3CA PIK3R2 PLCB1 PLP1 PMM2 PNKP PNPO PNPT1 POLG POLR3B POMGnT1 POMK POMT1 POMT2 PORCN PPT1 PQBP1 PRKCG PRKRA PRMT10 PRMT7 PRPS1 PRRT2 PRSS12 PSAP PTCH1 PTCHD1 PTEN PTPN11 PUF60 RAB18 RAB36

4 RAB39B RAB3GAP1 RAB3GAP2 RAD21 RAI1 RALGDS RANBP2 RARS2 RBBP8 RBM10 RELN RFT1 RGS7 RIT1 RMND1 RNASEH2A RNASEH2B RNASEH2C RNF168 RPGRIP1L RPL10 RPS6KA3 RTTN SALL1 SALL4 SAMHD1 SATB2 SCAPER SCLT1 SCN1A SCN2A SCN8A SCRIB SEMA3E SEPSECS SERPINA7 SETBP1 SETD2 SETD5 SETMAR SGK196 SHANK3 SHH SHOC2 SHROOM4 SIK1 SIM2 SIX3 SIX5 SKI SLC12A2 SLC16A2 SLC19A3 SLC25A19 SLC25A22 SLC25A5 SLC2A1 SLC31A1 SLC33A1 SLC35A1 SLC35A2 SLC35A3 SLC35C1 SLC4A4 SLC6A8 SLC9A6 SLITRK1 SMARCA2 SMARCA4 SMARCB1 SMARCE1 SMC1A SMC3 SMS SNAP29 SNX27 SOS1 SOX10 SOX2 SOX3 SOX5 SOX9 SPTAN1 SRCAP SRD5A3 SRF SRPX2 SSR4 ST3GAL3 ST3GAL5 STAG2 STAMBP STIL STT3A STT3B STXBP1 SUMF1 SURF1 SYN1 SYNGAP1 SYP SZT2 TAF1 TAF2 TAF6 TBC1D20 TBC1D24 TBC1D32 TBC1D7 TBX1 TCF4 TCTN1 TCTN2 TCTN3 TECR TH THOC2 THOC6 TIMM8A TM4SF20 TMCO1 TMEM135 TMEM138 TMEM165 TMEM216 TMEM231 TMEM237 TMEM5 TMEM67 TMPRSS4 TNK2 TRAPPC9 TREX1 TRIM32 TRIM32 TRIO TRMT1 TRMT10A TSC1 TSC2 TSEN2 TSEN34 TSEN54 TSPAN7 TTC21B TTC8 TTI2 TUBA1A TUBA8 TUBB2B TUBB3 TUBB4A TUBG1 TUBGCP6 TUSC3 TWIST1 UBE2A UBE3A UBR7

5 UPF3B VLDLR VPS13B VRK1 WAC WDR45 WDR45L WDR62 WDR81 WWOX XYLT1 ZBTB18 ZBTB20 ZBTB40 ZC3H14 ZC4H2 ZCCHC8 ZDHHC15 ZDHHC9 ZEB2 ZIC2 ZNF335 ZNF423 ZNF526 ZNF711.

6 Table S2: List of the 610 candidate genes targeted in the present study. AGO1 ACTL6A ACTL6B ADNP2 ADRB2 AEBP2 ALKBH8 AMIGO2 ANKRA2 ANKRD12 APBA1 APBB1 APPL1 APPL2 ARHGAP15 ARHGAP32 2 3B 4B ARIH1 ARL6 ARRB1 ASCC3 ASF1A ASF1B ASH1L ASH2L ASTN2 ASZ1 ATF2 ATF7IP ATXN7L3 AURKA AURKB AVPR1A BABAM1 BANP BAZ1A BAZ1B BAZ2A BAZ2B BCORL1 BDNF BHLHE41 BHMT BMI1 BMP4 BPTF BRD1 BRD4 BRD7 BRD8 BRE BRPF1 BRPF3 BRWD1 BTG1 BTG2 BZRAP1 C11ORF30 C14ORF169 C17ORF49 C2ORF86 CA6 CABIN1 CACNA1D CACNA1F CACNA1H CADM1 CADPS2 CAMK2G CAMTA2 CARM1 CBX1 CBX2 CBX4 CBX5 CBX6 CBX7 CBX8 CCDC101 CCDC28B CDH10 CDH11 CDH18 CDH2 CDH6 CDH9 CDYL CDYL2 CEBPB CHD1 CHD3 CHD4 CHD5 CHD6 CHD8 CHD9 CHL1 CHMP1B CIR1 CLOCK CNR1 CRABP1 CREB1 CSMD1 CSNK2A1 CSRP2BP CTCFL CTNND2 CTR9 CTXN1 CUX2 CXORF36 CXXC1 DAB1 DAPK1 DAPK3 DBX2 DCDC2 DDX17 DEK DGAT2 DGCR8 DISC1 DLG1 DLG2 DLG4 DLX1 DLX2 DMAP1 DNAJC2 DNER DNM3 DNMT3L DOT1L DPF3 DPP10 DPP6 DPY30 DR1 DRD1 DRD2 DRD3 DRD4 DSCAM EDF1 EED EEF2K EFEMP1 EGR1 EHMT2 EID1 ELP3 EMID2 EN2 ENY2 EP400 EPC1 EPC2 EPHA7 ERBB4 ESCO1 ETF1 EXOC6B EYA2 EYA3 EZH1 FAAH2 FAM175A FAM48A FAM65A FAT1 FBXO11 FBXO40 FHIT FLYWCH2 FOS FOXA2 FOXA3 FTSJ2 FTSJ3 FTSJD2 GABRA4 GABRB1 GABRB3 GABRD GALNT13 GATAD2A GFI1B GMNN GPC1 GPR6 GRIA2 GRID2 GRIK1 GRM3 GRM5 GRM7 GRM8 GRPR GRTP1 GSK3A GSPT1 GTF2IRD1 GTF3C4 H2AFY H2AFY2 HAT1 HDAC1 HDAC10 HDAC11 HDAC2 HDAC3 HDAC5 HDAC6 HDAC7 HDAC9 HENMT1 HES1 HEY2 HIC1 HIF1A HINFP HIRA HIVEP2 HLTF HMG20A HMG20B HMGN2 HMGN3 HNRNPU HOXB2 HS3ST1 HS6ST2 HTR1B HTR2A HTR3A HTR3C HTR7 ICMT ID1 IKZF1 ING2 ING3 ING4 ING5 ISL1 ITGAX ITGB1 KDM8 JMJD6 KANSL2 KANSL3 KAT2A KAT2B KAT5 KAT7 KAT8 KDM1A

7 KDM1B KDM2B KDM3A KDM3B KDM4A KDM4B KDM4C KDM4D KDM4DL KDM5B KPNA2 L3MBTL L3MBTL2 L3MBTL3 L3MBTL4 LARP6 LCMT1 LEO1 LIN7A LIX1 LMX1A LRFN5 LRWD1 LYNX1 MAEL MAGEA1 MAGEA2B MAP2 MAP2K3 MAP3K7 MAPK10 MAPK8 MAPRE3 MARCKS MARK1 MBD1 MBD2 MBD3 MBD4 MBD6 MBTD1 MCRS1 MDGA2 MEAF6 MECOM MED13 MED24 MEF2B MEF2D METTL11A METTL14 METTL3 MGEA5 MGLL MKRN3 MLH1 KMT2C MLL5 MORF4L1 MORF4L2 MPHOSPH8 MRGBP MSH2 MSL1 MSL2 MSL3 MTA1 MTA2 MTF1 MYB MYSM1 MYT1 NAA60 NAB2 NAV2 NCAM2 NCOA1 NCOA2 NCOA6 NCOR1 NCOR2 NDN NDNL2 NEFH NEK6 NELL2 NENF NGF NKAIN2 NKX3-1 NLGN1 NNAT NOTCH1 NPAS2 NPTX1 NR2C1 NR2E1 NRCAM NRG1 NRG4 NRIP1 NRP1 NRP2 NTAN1 NTF3 NTM NTN1 NTN4 NTNG1 NTRK1 NTRK2 NTRK3 NUDT21 OGT OLIG1 OPRM1 OXTR PADI4 PAF1 PAK1 PAX5 PAXIP1 PBRM1 PCDH10 PCDH11X PCDH8 PCDH9 PCGF1 PCNA PER1 PHB PHF1 PHF13 PHF15 PHF16 PHF17 PHF20 PICK1 PITX1 PKN1 PKN2 PLD6 POLE3 POLE4 PON1 PPARGC1B PRDM1 PRDM6 PRDM9 PRKAA1 PRKAA2 PRKCB PRKG2 PRMT2 PRMT3 PRMT5 PRMT6 PRMT8 PTF1A PTPRN2 PTPRT PYGO2 RAB3A RAB3B RAB3D RAB6A RAPGEF4 RASGEF1B RB1CC1 RBBP4 RBBP5 RBBP7 RBFOX1 RBL1 RBL2 RCBTB1 RCOR1 RERE REST RFWD2 RFX4 RGS6 RHOF RIMS3 RING1 RNF2 RNF20 RNF40 RNF8 ROBO1 RORB RPS6KA5 RSF1 RUVBL1 RUVBL2 RYBP SALL2 SALL3 SAP130 SAP18 SAP30 SATB1 SCRIB SDC3 SEMA4C SEMA5A SEMA6B SERPINI1 SETD1A SETD1B SETD3 SETD4 SETD6 SETD7 SETD8 SETDB1 SETDB2 SEZ6L2 SF3B1 SH3BGRL2 SHANK2 SIM1 SIN3A SIN3B SIRT1 SIRT2 SIRT6 SKP1 SLC25A12 SLC4A10 SLC6A1 SLC6A3 SLC6A4 SLC9A9 SLITRK2 SLITRK4 SMARCA5 SMARCAD1 SMARCC1 SMARCC2 SMARCD1 SMARCD2 SMARCD3 SMYD2 SMYD3 SP1 SP2 SP5 SPEN SPOCK1 SRFBP1 SS18L1 STAG1 STK24 STMN2 STX1A SUDS3 SUPT16H SUPT3H SUPT7L SUV39H1 SUV39H2 SUV420H1 SUV420H2 SUZ12 SYCP1 SYN2 SYNCRIP SYT1 TADA1 TADA2A TADA2B TAF10 TAF12 TAF1L

8 TAF4 TAF5 TAF5L TAF6L TAF7 TAL1 TBL1X TBL1XR1 TCF21 TDRD1 TDRD3 TDRD5 TDRD9 TET1 TFAP4 THBD TLE3 TLK1 TLK2 TMEM195 TMEM66 TMOD2 TNFRSF19 TOP2A TOP2B TOPBP1 TRAF6 TRIM45 TRMT112 TRPC5 TRRAP TSPYL2 UBAC2 UBAP2L UBE2B UBE2E1 UBE2H UBE2N UBN1 UBR2 UHRF1BP1 UNC5A USF1 USP16 USP21 USP22 USP3 UTP3 VPS72 VSNL1 WDR13 WDR5 WDR7 WDR8 WDR82 WHSC1 WHSC1L1 NELFA WSB1 YEATS2 YEATS4 YWHAB YWHAE YWHAH YY1 ZBTB7A ZDHHC14 ZFHX4 ZMYM3 ZMYND15 ZMYND8 ZNF217 ZNF347 ZNF385B ZNF721 ZNF804A

9 Table S3: Selection of variants of unknown or probably benign significance. See the text for further commentaries. Patient Gene Genomic position (hg19) transcript coding Protein Inheritance 6 ASCC3 chr6: NM_ c.1464dupc p.tyr489leufster5 de novo 12 CACNA1H chr16: NM_ c.2389c>t p.arg797cys de novo 37 CTCFL chr20: NM_ c.394c>t p.gln132ter de novo 38 HUWE1 chrx: NM_ c.344c>t p.ser115phe de novo 39 PDE4D chr5: NM_ c.65+2t>a splicing? de novo 40 C22orf39 chr22: NM_ c.244t>c p.trp82arg de novo 41 NLGN4X chrx: NM_ c.1361_1372del12 p.val454_ala457del de novo 42 BCOR chrx: NM_ c.4981c>t p.arg1661ter maternal (X-linked) 43 SHROOM4 chrx: NM_ c.2512_2514delcat p.his838del maternal (X-linked) 44 MECP2 chrx: NM_ c.1164_1172del9 + c.1191_1202del12 + c.1219_1227del9 p.lys389_pro391del+ Leu398_Pro401del + Ser407_Glu409del maternal (X-linked)

10 Table S4: Main clinical characteristics of the patients with pathogenic or probably pathogenic variants, as well as some variants of unknown clinical consequence. Patient DECIPHER ID Chr. sex Gene HGVS code Genotype Phenotype XY MED12 chrx:g g>a Hemizygous XX NFIX chr19:g ct>c Heterozygous XX CASK chrx:g a>c Heterozygous XX NIPBL chr5:g caat>c Heterozygous Abnormality of the genitourinary system, Blepharophimosis, Brachycephaly, Depressed nasal bridge, Growth delay, Hypertonia, Intellectual disability, Microcephaly, Microretrognathia, Muscular hypotonia, Postnatal growth retardation Abnormality of the fontanelles or cranial sutures, Abnormality of the hair, Abnormality of the hand, Abnormality of the mouth, Abnormality of the palate, Abnormality of the philtrum, Abnormality of the teeth, Decreased body weight, Downslanted palpebral fissures, Feeding difficulties, Feeding difficulties in infancy, Hearing impairment, Intellectual disability, Intrauterine growth retardation, Motor delay, Muscular hypotonia, Neonatal hypotonia, Pierre-Robin sequence, Prominent forehead, Short stature Abnormality of the nose, Aggressive behavior, Delayed speech and language development, Hypertelorism, Hypertonia, Intellectual disability, Intrauterine growth retardation, Low-set ears, Microcephaly, Micrognathia, Motor delay, Muscular hypotonia, Stereotypic behavior Abnormality of the hair, Abnormality of the hand, Abnormality of the mouth, Abnormality of the nose, Abnormality of the philtrum, Abnormality of the skeletal system, Abnormality of the teeth, Delayed speech and language development, Facial asymmetry, Hyperactivity, Hypertelorism, Intellectual disability, Intrauterine growth retardation, Macrotia, Low-set ears, Microcephaly, Synophrys, Upslanted palpebral fissure

11 XY KMT2D chr12:g ga>g Heterozygous XY RPS6KA3 chrx:g t>a Hemizygous XY SLC16A2 chrx:g c>t Hemizygous XY UBE3A chr15:g c>t Heterozygous XY NSDHL chrx:g g>a Hemizygous hair, Abnormality of the mouth, Abnormality of the nose, Abnormality of the palate, Abnormality of the philtrum, Abnormality of the skeletal system, Anteverted ears, Autistic behavior, Decreased body weight, Delayed speech and language development, Feeding difficulties, Hearing impairment, Intellectual disability, Macrotia, Low-set ears, Mandibular prognathia, Microcephaly, Motor delay, Muscular hypotonia, Short stature, Stereotypic behavior Abnormality of the male genitalia, Abnormality of the nose, Abnormality of the palate, Abnormality of the philtrum, Abnormality of the skeletal system, Abnormality of the teeth, Aggressive behavior, Anteverted ears, Decreased body weight, Delayed closure of the anterior fontanelle, Delayed speech and language development, Epicanthus, Hypermetropia, Hypertelorism, Hypertrichosis, Intellectual disability, Intrauterine growth retardation, Macrotia, Long eyebrows, Low anterior hairline, Low-set ears, Motor delay, Muscular hypotonia, Neonatal hypotonia, Pierre-Robin sequence, Short palm, Short stature, Sleep disturbance, Tapered finger, Thick vermilion border Abnormality of the hand, Abnormality of the head, Abnormality of the mouth, Abnormality of the palate, Autistic behavior, Delayed speech and language development, Epicanthus, Hypertelorism, Intellectual disability, Motor delay, Muscular hypotonia, Neonatal hypotonia, Nystagmus, Sleep disturbance Gait disturbance, Happy demeanor, Intellectual disability, Microcephaly, Poor speech Severe intellectual disability, Seizures, Spasticity, Atrophy of optic discs, Microcephaly, Plagiocephaly, Skeletal abnormalities, High nasal bridge, Strabismus, Micrognathia

12 XY TAF1 chrx:g g>c Hemizygous XX SMC3 chr10:g g>a Heterozygous XX DYRK1A chr21:g acagat>a Heterozygous XY SETBP1 chr18:g t>c Heterozygous XX PTPN11 chr12:g a>g Heterozygous hair, Abnormality of the male genitalia, Abnormality of the skeletal system, Decreased body weight, Intrauterine growth retardation, Low-set ears, Microcephaly, Motor delay, Pierre- Robin sequence, Strabismus hair, Abnormality of the hand, Abnormality of the nose, Abnormality of the palate, Abnormality of the skeletal system, Facial asymmetry, Feeding difficulties, Hearing impairment, Hypertrichosis, Intellectual disability, Intrauterine growth retardation, Long eyebrows, Low-set ears, Microcephaly, Neonatal hypotonia, Synophrys hair, Abnormality of the hand, Abnormality of the mouth, Abnormality of the nose, Abnormality of the palate, Abnormality of the philtrum, Abnormality of the teeth, Delayed speech and language development, Downslanted palpebral fissures, Hypertelorism, Intellectual disability, Low-set ears, Microcephaly, Micrognathia, Motor delay, Short stature, Stereotypic behavior, Symptomatic seizures hand, Abnormality of the male genitalia, Abnormality of the mouth, Abnormality of the philtrum, Abnormality of the skeletal system, Decreased body weight, Feeding difficulties in infancy, Hearing impairment, Hypertonia, Intellectual disability, Low-set ears, Microcephaly, Micrognathia, Motor delay, Muscular hypotonia, Short stature, Symptomatic seizures hair, Abnormality of the nose, Decreased body weight, Downslanted palpebral fissures, Hypertelorism, Intellectual disability, Intrauterine growth retardation, Macrotia, Low-set ears, Macrocephaly, Motor delay, Muscular hypotonia,

13 Prominent forehead, Short stature, Symptomatic seizures XY KMT2A chr11:g t>ta Heterozygous XY MED13L chr12:g c>t Heterozygous XY MED13L chr12:g g>a Heterozygous hand, Abnormality of the male genitalia, Abnormality of the nose, Abnormality of the palate, Abnormality of the philtrum, Aggressive behavior, Decreased body weight, Delayed speech and language development, Downslanted palpebral fissures, Feeding difficulties, Hypertelorism, Hypertrichosis, Intellectual disability, Low-set ears, Microcephaly, Motor delay, Muscular hypotonia, Neonatal hypotonia, Pierre-Robin sequence, Posteriorly rotated ears, Short stature, Telecanthus Aggressive behavior, Autism spectrum disorder, Decreased body weight, Depressed nasal bridge, Downslanted palpebral fissures, Hearing impairment, Intellectual disability, Low-set ears, Muscular hypotonia Dental crowding, Depressed nasal bridge, Downslanted palpebral fissures, Intellectual disability, Low-set ears, Moderately short stature, Muscular hypotonia, Prominent forehead, Unilateral renal agenesis XY KDM6A chrx:g tcagatga CGG>T Hemizygous Abnormality of the mouth, Abnormality of the nose, Abnormality of the palate, Abnormality of the philtrum, Anteverted ears, Decreased body weight, Delayed speech and language development, Epicanthus, Hyperactivity, Intellectual disability, Low-set ears, Microcephaly, Motor delay, Myopia, Short stature, Strabismus XX ZBTB20 chr3:g c>g Heterozygous Abnormality of the hair, Abnormality of the hand, Abnormality of the mouth, Abnormality of the nose, Abnormality of the philtrum, Abnormality of the skeletal system, Abnormality of the teeth, Agenesis of corpus callosum, Aggressive behavior, Anteverted ears, Autistic behavior, Delayed speech and language development, Downslanted palpebral fissures, Epicanthus,

14 Feeding difficulties, Hypertelorism, Hypertrichosis, Intellectual disability, Macrocephaly, Motor delay, Muscular hypotonia, Prominent forehead, Sleep disturbance, Strabismus XX NDST1 chr5:g g>a Homozygous XX KCNT1 chr9:g g>a Heterozygous XX 1B chr6:g c>t Heterozygous XX KMT2D chr12:g gt>g Heterozygous Abnormality of the mouth, Abnormality of the nose, Abnormality of the skeletal system, Aggressive behavior, Anteverted ears, Decreased body weight, Delayed speech and language development, Developmental regression, Hyperactivity, Hypertelorism, Hypertonia, Intellectual disability, Motor delay, Muscular hypotonia, Stereotypic behavior, Symptomatic seizures Abnormality of the hand, Abnormality of the mouth, Abnormality of the nose, Abnormality of the philtrum, Abnormality of the teeth, Delayed speech and language development, Hypertrichosis, Intellectual disability, Microcephaly, Motor delay, Muscular hypotonia, Sleep disturbance, Stereotypic behavior, Strabismus, Symptomatic seizures Abnormality of the hair, Abnormality of the hand, Abnormality of the mouth, Abnormality of the palate, Abnormality of the philtrum, Abnormality of the teeth, Decreased body weight, Delayed speech and language development, Feeding difficulties, Feeding difficulties in infancy, Hypertelorism, Hypertrichosis, Intellectual disability, Intrauterine growth retardation, Micrognathia, Motor delay, Muscular hypotonia, Myopia, Neonatal hypotonia, Short stature, Upslanted palpebral fissure hair, Abnormality of the hand, Abnormality of the mouth, Abnormality of the palate, Abnormality of the skeletal system, Abnormality of the teeth, Autistic behavior, Facial asymmetry, Hearing impairment, Hypertrichosis, Intellectual disability, Macrotia, Low-set ears, Microcephaly, Motor delay, Muscular hypotonia, Stereotypic behavior

15 XY ANKRD11 chr16:g cctca>c Heterozygous XY RAD21 chr8:g c>t Heterozygous XX KMT2A chr11:g tc>t Heterozygous Abnormality of the hair, Abnormality of the hand, Abnormality of the male genitalia, Abnormality of the mouth, Abnormality of the nose, Abnormality of the philtrum, Abnormality of the skeletal system, Abnormality of the teeth, Anteverted ears, Autistic behavior, Delayed speech and language development, Facial asymmetry, Feeding difficulties, Hyperactivity, Hypertelorism, Intellectual disability, Intrauterine growth retardation, Long eyebrows, Low-set ears, Macrocephaly, Motor delay, Muscular hypotonia, Neonatal hypotonia, Prominent forehead, Stereotypic behavior, Synophrys, Upslanted palpebral fissure Abnormality of the hand, Abnormality of the male genitalia, Abnormality of the philtrum, Anteverted ears, Decreased body weight, Delayed speech and language development, Intellectual disability, Intrauterine growth retardation, Macrotia, Long eyebrows, Low-set ears, Microcephaly, Myopia Abnormality of the hair, Abnormality of the hand, Abnormality of the mouth, Abnormality of the nose, Abnormality of the palate, Abnormality of the philtrum, Aggressive behavior, Delayed speech and language development, Epicanthus, Hypertelorism, Hypertrichosis, Intellectual disability, Intrauterine growth retardation, Macrotia, Microcephaly, Posteriorly rotated ears, Short stature, Strabismus, Synophrys XY PIGN chr18:g g>a + chr18:g at>a Heterozygous Abnormality of the hand, Abnormality of the mouth, Abnormality of the nose, Abnormality of the teeth, Anteverted ears, Delayed speech and language development, Epicanthus, Increased body weight, Intellectual disability, Motor delay, Muscular hypotonia, Neonatal hypotonia, Stereotypic behavior, Symptomatic seizures, Tall stature XY KMT2D chr12:g g>a Heterozygous fontanelles or cranial sutures, Abnormality of the hand, Abnormality of the nose, Abnormality of the palate, Decreased body weight, Feeding difficulties, Intellectual disability,

16 Intrauterine growth retardation, Micrognathia, Motor delay, Muscular hypotonia, Neonatal hypotonia, Short stature, Upslanted palpebral fissure XX 1A chr1:g a>t Heterozygous XY AGO1 chr1:g g>a Heterozygous XY J2 chr6:g c>t Heterozygous XY SIN3B chr19:g ca>c Heterozygous hand, Abnormality of the mouth, Abnormality of the nose, Abnormality of the palate, Agenesis of corpus callosum, Aggressive behavior, Decreased body weight, Delayed speech and language development, Facial asymmetry, Feeding difficulties, Hypertonia, Hypertrichosis, Intellectual disability, Macrotia, Long eyebrows, Motor delay, Muscular hypotonia, Pierre-Robin sequence, Short stature, Strabismus, Symptomatic seizures Abnormality of the kidney, Abnormality of the mouth, Abnormality of the nose, Autistic behavior, Delayed speech and language development, Epicanthus, Hyperactivity, Increased body weight, Intellectual disability, Macrotia, Motor delay, Muscular hypotonia, Sleep disturbance, Stereotypic behavior, Tall stature Abnormality of the hand, Abnormality of the nose, Autistic behavior, Blindness, Delayed speech and language development, Downslanted palpebral fissures, Increased body weight, Intellectual disability, Motor delay, Muscular hypotonia, Stereotypic behavior, Strabismus, Synophrys Abnormality of the hair, Abnormality of the nose, Aggressive behavior, Autistic behavior, Delayed speech and language development, Hearing impairment, Increased body weight, Intellectual disability, Macrocephaly, Motor delay, Muscular hypotonia, Neonatal hypotonia, Prominent forehead, Stereotypic behavio

17 XY FBXO11 chr2:g cat>c Heterozygous XY MAP3K7 chr6:g g>a Heterozygous XX HDAC2 chr6:g c>t Heterozygous XX SMARCC2 chr12:g g>c Heterozygous XX CTCFL chr20:g g>a Heterozygous XX HUWE1 chrx:g g>a Heterozygous Abnormality of the hand, Abnormality of the kidney, Abnormality of the philtrum, Abnormality of the skeletal system, Anteverted ears, Autistic behavior, Decreased body weight, Delayed speech and language development, Epicanthus, Intrauterine growth retardation, Microcephaly, Motor delay, Stereotypic behavior, Strabismus Abnormality of the male genitalia, Abnormality of the nose, Abnormality of the philtrum, Abnormality of the skeletal system, Hypertelorism, Intellectual disability, Intrauterine growth retardation, Micrognathia Autistic behavior, Delayed speech and language development, Developmental regression, Hyperactivity, Intellectual disability, Muscular hypotonia, Stereotypic behavior, Symptomatic seizures Abnormality of the hand, Abnormality of the mouth, Abnormality of the nose, Abnormality of the skeletal system, Decreased body weight, Delayed speech and language development, Hypertrichosis, Intellectual disability, Intrauterine growth retardation, Microcephaly, Motor delay, Muscular hypotonia, Short stature, Sleep disturbance, Symptomatic seizures, Synophrys hand, Abnormality of the kidney, Abnormality of the teeth, Delayed speech and language development, Downslanted palpebral fissures, Feeding difficulties, Hearing impairment, Intellectual disability, Intrauterine growth retardation, Macrotia, Low-set ears, Micrognathia, Motor delay, Muscular hypotonia, Neonatal hypotonia Abnormality of the mouth, Abnormality of the nose, Autistic behavior, Decreased body weight, Delayed speech and language development, Hypertelorism, Hypertonia, Intellectual disability, Intrauterine growth retardation, Macrotia, Low-set

18 ears, Motor delay, Short stature, Stereotypic behavior, Symptomatic seizures, Upslanted palpebral fissure XY PDE4D chr5:g a>t Heterozygous XY C22orf39 chr22:g a>g Heterozygous Abnormality of the mouth, Abnormality of the philtrum, Abnormality of the teeth, Aggressive behavior, Delayed speech and language development, Hyperactivity, Hypermetropia, Hypertelorism, Intellectual disability, Low-set ears, Motor delay, Muscular hypotonia, Stereotypic behavior, Symptomatic seizures Abnormality of the hair, Abnormality of the mouth, Abnormality of the nose, Abnormality of the palate, Abnormality of the teeth, Autistic behavior, Delayed speech and language development, Epicanthus, Hearing impairment, Hypertrichosis, Hypotelorism, Intellectual disability, Long eyebrows, Low-set ears, Macrocephaly, Motor delay, Symptomatic seizures XY NLGN4X chrx:g tcggcggt GGCCA>T Hemizygous Abnormality of the mouth, Abnormality of the skeletal system, Abnormality of the teeth, Aggressive behavior, Anteverted ears, Autistic behavior, Feeding difficulties, Hyperactivity, Hypertonia, Intellectual disability, Low-set ears, Microcephaly, Motor delay, Muscular hypotonia, Posteriorly rotated ears, Retrognathia, Sleep disturbance, Stereotypic behavior, Strabismus XY BCOR chrx:g g>a Hemizygous hand, Abnormality of the male genitalia, Abnormality of the mouth, Abnormality of the philtrum, Autistic behavior, Blindness, Decreased body weight, Delayed speech and language development, Downslanted palpebral fissures, Epicanthus, Facial asymmetry, Feeding difficulties, Hypertelorism, Intellectual disability, Mandibular prognathia, Microcephaly, Motor delay, Muscular hypotonia, Myopia, Neonatal hypotonia, Nystagmus, Ptosis, Stereotypic behavior, Strabismus XY SHROOM4 chrx:g catg>c Hemizygous Intellectual disability

19 XY ASCC3 chr6:g.chr6: a>ag Heterozygous XX CACNA1H chr16:g c>t Heterozygous Abnormality of the male genitalia, Abnormality of the nose, Abnormality of the palate, Abnormality of the philtrum, Abnormality of the skeletal system, Abnormality of the teeth, Aggressive behavior, Anteverted ears, Decreased body weight, Delayed closure of the anterior fontanelle, Delayed speech and language development, Epicanthus, Hypermetropia, Hypertelorism, Hypertrichosis, Intellectual disability, Intrauterine growth retardation, Macrotia, Long eyebrows, Low anterior hairline, Low-set ears, Motor delay, Muscular hypotonia, Neonatal hypotonia, Pierre-Robin sequence, Short palm, Short stature, Sleep disturbance, Tapered finger, Thick vermilion border hair, Abnormality of the hand, Abnormality of the mouth, Abnormality of the nose, Abnormality of the palate, Abnormality of the philtrum, Abnormality of the teeth, Delayed speech and language development, Downslanted palpebral fissures, Hypertelorism, Intellectual disability, Low-set ears, Microcephaly, Micrognathia, Motor delay, Short stature, Stereotypic behavior, Symptomatic seizures

devseek (Sequence(Analysis(Panel(for(Neurodevelopmental(Disorders

devseek (Sequence(Analysis(Panel(for(Neurodevelopmental(Disorders ACSL4 Mental/retardation,/XBlinked/63 XLBR ADSL Adenylosuccinase/Deficiency AR AFF2 Mental/retardation,/XBlinked,/FRAXE/type XLBR ALG6 Congenital/disorder/of/glycosylation/type/Ic AR ANK3 Mental/retardation,/autosomal/recessive/37

More information

Targeted Genes and Methodology Details for Epilepsy/Seizure Genetic Panels

Targeted Genes and Methodology Details for Epilepsy/Seizure Genetic Panels Targeted s and Methodology Details for Epilepsy/Seizure tic Panels Reference transcripts based on build GRCh37 (hg19) interrogated by Epilepsy/Seizure tic Panels Epilepsy Expanded Panel Epilepsy Expanded

More information

'Translating massively parallel sequencing into clinical diagnostics.

'Translating massively parallel sequencing into clinical diagnostics. 'Translating massively parallel sequencing into clinical diagnostics. SA Pathology at the Women s and and The University of Adelaide Adelaide, Australia MPS is revolutionising genetics & biology - >100

More information

Development Supplementary Material

Development Supplementary Material Fig. S1. Cell fate analyses of VAD model mice (related to Fig. 2). Fate of pulse-labeled NGN3+ cells following VA administration. The same protocol was used as in Fig. 2A. (A) The experimental schedule.

More information

Nature Genetics: doi: /ng Supplementary Figure 1. Depths and coverages in whole-exome and targeted deep sequencing data.

Nature Genetics: doi: /ng Supplementary Figure 1. Depths and coverages in whole-exome and targeted deep sequencing data. Supplementary Figure 1 Depths and coverages in whole-exome and targeted deep sequencing data. Depth (top) and coverage (bottom) of whole-exome sequencing for 38 independent JPN cases (mean depth = 130)

More information

Reverse phenotyping: MCD Detection without clinical diagnosis. Diagnostic: NGS panels versus WES

Reverse phenotyping: MCD Detection without clinical diagnosis. Diagnostic: NGS panels versus WES Clinical Genetics Leading the way in genetic issues Reverse phenotyping: MCD Detection without clinical diagnosis Diagnostic: NGS panels versus WES Martina Wilke Laboratory Specialist Clinical Genetics

More information

ERN EpiCARE. A European Reference Network for Rare and Complex Epilepsies. Petr Marusic Motol University Hospital, Prague

ERN EpiCARE. A European Reference Network for Rare and Complex Epilepsies. Petr Marusic Motol University Hospital, Prague ERN EpiCARE A European Reference Network for Rare and Complex Epilepsies Petr Marusic Motol University Hospital, Prague Disclosure I have no actual or potential conflict of interest in relation to this

More information

A European Reference Network for rare and complex epilepsies. J Helen Cross Coordinator

A European Reference Network for rare and complex epilepsies. J Helen Cross Coordinator A European Reference Network for rare and complex epilepsies J Helen Cross Coordinator The epilepsies a group of rare diseases Early myoclonic encephalopathy PIGA, SETBP1, SIK1, SLC25A22 Dravet syndrome

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION SUPPLEMENTARY INFORMATION doi:1.138/nature12912 Figure S1. Distribution of mutation rates and spectra across 4,742 tumor-normal (TN) pairs from 21 tumor types, as in Figure 1 from Lawrence et al. Nature

More information

The University of Chicago Genetic Services Laboratories

The University of Chicago Genetic Services Laboratories Aceruloplasminemia testing CP sequencing Aceruloplasminemia CP deletion/duplication Albinism testing Albinism Sequencing Panel (20 genes Albinism Deletion/Duplication Panel (20 genes Alstrom syndrome testing

More information

Clinical Diagnosis of Mendelian Disorders Using a Comprehensive Gene-Targeted Panel Test for Next-Generation Sequencing

Clinical Diagnosis of Mendelian Disorders Using a Comprehensive Gene-Targeted Panel Test for Next-Generation Sequencing Yonago Acta medica 2016;59:118 125 Original Article Clinical Diagnosis of Mendelian Disorders Using a Comprehensive Gene-Targeted Panel Test for Next-Generation Sequencing Tetsuya Okazaki,* Megumi Murata,

More information

Supplementary Table 1. Information on the 174 single nucleotide variants identified by whole-exome sequencing

Supplementary Table 1. Information on the 174 single nucleotide variants identified by whole-exome sequencing Supplementary Table 1. Information on the 174 single nucleotide s identified by whole-exome sequencing Chr Position Type AF exomes Database 1 10163148 A/G UBE4B missense 0.000326 1534 2 98 1 4.44 Damaging

More information

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 4,000 116,000 120M Open access books available International authors and editors Downloads Our

More information

A Targeted Next Generation Sequencing (tngs) Screening Assay for Menkes Disease and its Implications for Primary DNA-based Newborn Screening

A Targeted Next Generation Sequencing (tngs) Screening Assay for Menkes Disease and its Implications for Primary DNA-based Newborn Screening A Targeted Next Generation Sequencing (tngs) Screening Assay for Menkes Disease and its Implications for Primary DNA-based Newborn Screening Richard B. Parad 1, Stephen G. Kaler 2, Evan Mauceli 4, Tanya

More information

Subject ID: Date Test Started: Specimen Type: Peripheral Blood Date of Report: Date Specimen Obtained:

Subject ID: Date Test Started: Specimen Type: Peripheral Blood Date of Report: Date Specimen Obtained: TEST PERFORMED Whole exome sequencing (WES) with Focused Diagnostic Panel(s): Neuropathy, Leukodystrophy, Myopathy See below for a complete list of genes analyzed. RESULTS 1 sequence variant with potential

More information

Whole exome sequencing Gene package Autism version 2,

Whole exome sequencing Gene package Autism version 2, Whole Exome Sequencing Gene package Autism, version 2, 1 7 2017 Technical information After DNA was enriched using Agilent Sureselect Clinical Research Exome (CRE) Capture, samples were run on the Illumina

More information

Unique, expert portfolio

Unique, expert portfolio EPIGENETICS Enzymes Kits Cell Lines Screening Services INNOVATIVE PRODUCTS TO FUEL YOUR EXPERIMENTS Unique, expert portfolio www.bpsbioscience.com HISTONE METHYLTRANSFERASES HISTONE DEMETHYLASES ACETYLTRANSFERASES

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Tan TY, Dillon OJ, Stark Z, et al. Diagnostic effect and cost-effectiveness of whole-exome sequencing of ambulant children with suspected monogenic conditions. JAMA Pediatr.

More information

Whole exome sequencing Gene package Autism version 2.1,

Whole exome sequencing Gene package Autism version 2.1, Whole Exome Sequencing Gene package Autism, version 2.1, 22 11 2017 Technical information DNA was enriched using Agilent SureSelect Clinical Research Exome V2 capture and paired end sequenced on the Illumina

More information

Jocelyn Chapman, MD Division of Gynecologic Oncology. Julie S. Mak, MS, MSc Genetic Counselor Hereditary Cancer Clinic

Jocelyn Chapman, MD Division of Gynecologic Oncology. Julie S. Mak, MS, MSc Genetic Counselor Hereditary Cancer Clinic Jocelyn Chapman, MD Division of Gynecologic Oncology Julie S. Mak, MS, MSc Genetic Counselor Hereditary Cancer Clinic Genetics underlies all cancers Somatic or tumor genetics Germline or inherited genetics

More information

Family Education and Support

Family Education and Support Family Education and Support Key Topics First Aid Seizure Safety Sports Physical Activity Driving Familial Psychosocial Needs in Treating Pediatric Epilepsy Poll Question 1 Which of the following is not

More information

Integrative Radiation Biology

Integrative Radiation Biology Dr. Kristian Unger Integrative Biology Group Research Unit of Radiation Cytogenetics Department of Radiation Sciences Helmholtz-Zentrum München 1 Key Questions Molecular mechanisms of radiation-induced

More information

The Japanese collaborated study of Fragile X syndrome and its related disorders

The Japanese collaborated study of Fragile X syndrome and its related disorders The Japanese collaborated study of Fragile X syndrome and its related disorders Yuji Nakayama, PhD Research Center for Bioscience and Technology, Tottori University, Japan TOTTORI Tsukuba Kyoto TOKYO Okayama

More information

Role of Molecular Genetic Assessment for Autism in Clinical Setting

Role of Molecular Genetic Assessment for Autism in Clinical Setting Role of Molecular Genetic Assessment for Autism in Clinical Setting Young Shin Kim, MD, MS, MPH, PhD Director STAR Center for ASD and NDDs Psychiatric Genetic Epidemiology Associate Professor Dept. of

More information

Quick Guide To Genetic Testing

Quick Guide To Genetic Testing Aceruloplasminemia testing CP sequencing 2101 81406 4 weeks $1,000 Aceruloplasminemia CP deletion/duplication 2102 81405 4 weeks $1,000 Albinism testing Albinism Sequencing ** 1101 81407 8 weeks $2,500

More information

Dr. Sarah Weckhuysen, MD, PhD. Neurogenetics Group, VIB-Department of Molecular Genetics University of Antwerp, Belgium

Dr. Sarah Weckhuysen, MD, PhD. Neurogenetics Group, VIB-Department of Molecular Genetics University of Antwerp, Belgium Dr. Sarah Weckhuysen, MD, PhD Neurogenetics Group, VIB-Department of Molecular Genetics University of Antwerp, Belgium Common Prevalence 4-8/1000 Life time incidence 3% Key symptom = seizures Nature Reviews

More information

CilioPathy panel. 3-Jul-2018 (102 genen) Centrum voor Medische Genetica Gent. versie. OMIM gene ID

CilioPathy panel. 3-Jul-2018 (102 genen) Centrum voor Medische Genetica Gent. versie. OMIM gene ID versie 3-Jul-2018 (102 genen) CilioPathy panel Centrum voor Medische Genetica Gent Gene OMIM gene ID Associated phenotype, OMIM phenotype ID, phenotype mapping key and inheritance pattern AHI1 608894 Joubert

More information

Quick Guide To Genetic Testing

Quick Guide To Genetic Testing Aceruloplasminemia testing CP sequencing 2101 81406 4 weeks $1,000 Aceruloplasminemia CP deletion/duplication 2102 81405 4 weeks $1,000 Albinism testing Albinism Sequencing Panel** 1101 81407 8 weeks $2,500

More information

Requisition for DNA Testing. Reason for Referral: Patient Information: INCOMPLETE REQUESTS WILL BE BANKED. Test Requests: Sample Collection:

Requisition for DNA Testing. Reason for Referral: Patient Information: INCOMPLETE REQUESTS WILL BE BANKED. Test Requests: Sample Collection: Reason for Referral: Diagnostic Testing: Affected Unaffected Carrier testing/known Family Mutation Name of index case in the family (include copy of report): Date of Birth: Relationship to this patient:

More information

PITTSBURGH CYTOGENETICS LABORATORY

PITTSBURGH CYTOGENETICS LABORATORY PITTSBURGH CYTOGENETICS LABORATORY GENES COVERED BY X-HR AND SYNDROMES DETECTED BY X-HR # GENES LOCI DISORDERS 1 ABCB7 Xq12-q13 Anemia, sideroblastic, with ataxia 2 ABCD1 Xq28 Adrenoleukodystrophy 3 ACSL4

More information

Title Targeting p300 addiction in CBP-deficient cancers causes synthetic lethality by apoptotic cell death due to abrogation of MYC expression

Title Targeting p300 addiction in CBP-deficient cancers causes synthetic lethality by apoptotic cell death due to abrogation of MYC expression Supplementary Information Cancer Discovery Title Targeting p3 addiction in CBP-deficient cancers causes synthetic lethality by apoptotic cell death due to abrogation of MYC expression Authors Hideaki Ogiwara

More information

Request for expedited Result

Request for expedited Result London Health Sciences Centre Molecular Genetics Laboratories Requisition for DNA Testing DACC002 REV 20170815 AUTHORIZED SIGNATURE IS REQUIRED INCOMPLETE REQUESTS WILL BE BANKED Molecular Genetics Laboratory

More information

Plasma-Seq conducted with blood from male individuals without cancer.

Plasma-Seq conducted with blood from male individuals without cancer. Supplementary Figures Supplementary Figure 1 Plasma-Seq conducted with blood from male individuals without cancer. Copy number patterns established from plasma samples of male individuals without cancer

More information

Epilepsy. Genetic Test Submission Guide. 2. Samples. 1. Forms. 3. Ship RESULTS. impactgenetics.com

Epilepsy. Genetic Test Submission Guide. 2. Samples. 1. Forms. 3. Ship RESULTS. impactgenetics.com Epilepsy Genetic Test Submission Guide 1. Forms 2. Samples Form 1d: If applicable Form 1b: Requisition Form Form 1a: Informed Consent 3. Ship RESULTS Impact Genetics, Dynacare 4-1100 Bennett Rd. Bowmanville,

More information

Supplementary Table 1. Candidate loci that were associated with diabetes- and/or obesity-related traits.

Supplementary Table 1. Candidate loci that were associated with diabetes- and/or obesity-related traits. Supplementary Table 1. Candidate loci that were associated with diabetes- and/or obesity-related traits. All With Fst in the With long With SNP(s) at the 5' top 5% bracket haplotypes regulatory region

More information

Lions and Tigers and Bears.Oh My!

Lions and Tigers and Bears.Oh My! Lions and Tigers and Bears.Oh My! TAKING THE FEAR OUT OF GENETIC TESTING Lisa Butterfield, MS, CGC Genetic Counselor Clinical Assistant Professor University of Kansas Health System Why is Genetic Testing

More information

Introducing the cerebellum. Mid-hindbrain morphogenesis. Famous paper towel model - CBL 1/19/2017

Introducing the cerebellum. Mid-hindbrain morphogenesis. Famous paper towel model - CBL 1/19/2017 Introducing the cerebellum Canary in the coal mine: the cerebellum as a sentinel for developmental brain disorders Highly conserved structure and function Foliation conserved across evolution Structure

More information

Precision Oncology: Experience at UW

Precision Oncology: Experience at UW Precision Oncology: Experience at UW Colin Pritchard MD, PhD University of Washington, Department of Lab Medicine WSMOS Meeting November 1, 2013 Conflict of Interest Disclosures I declare the following,

More information

Supplementary information: Forstner, Hofmann et al.

Supplementary information: Forstner, Hofmann et al. Supplementary information: Forstner, Hofmann et al., Genome-wide analysis implicates micrornas and their target genes in the development of bipolar disorder Table of contents Supplementary Figure 1: Regional

More information

Targeted Agent and Profiling Utilization Registry (TAPUR ) Study. February 2018

Targeted Agent and Profiling Utilization Registry (TAPUR ) Study. February 2018 Targeted Agent and Profiling Utilization Registry (TAPUR ) Study February 2018 Precision Medicine Therapies designed to target the molecular alteration that aids cancer development 30 TARGET gene alterations

More information

Name: Last First Date of Birth (mm/dd/yyyy): Gender: Male Female MRN: Ethnicity: Caucasian African-American Hispanic Asian Ashkenazi Jewish Other

Name: Last First Date of Birth (mm/dd/yyyy): Gender: Male Female MRN: Ethnicity: Caucasian African-American Hispanic Asian Ashkenazi Jewish Other Requisition Form 5841 South Maryland Avenue, Room G701/MC0077, Chicago, IL 60637 Toll Free: 888.824.3637 Local: 773.834.0555 Fax: 773.702.9130 ucgslabs@genetics.uchicago.edu dnatesting.uchicago.edu CLIA#:

More information

Whole Exome Sequencing Gene package Neuronal migration disorders Version 3,

Whole Exome Sequencing Gene package Neuronal migration disorders Version 3, Whole Exome Sequencing Gene package Neuronal migration disorders, version 3, 1 2 2018 Technical information DNA was enriched using Agilent SureSelect Clinical Research Exome V2 capture and paired end sequenced

More information

Comprehensive genetic testing for hearing and vision loss

Comprehensive genetic testing for hearing and vision loss Comprehensive genetic testing for hearing and vision loss Hearing and vision loss can result from both genetic and non-genetic etiologies In general, there is a genetic basis for up to 50% of prelingual

More information

Quantitative Real Time PCR (RT-qPCR) Differentiation of human preadipocytes to adipocytes

Quantitative Real Time PCR (RT-qPCR) Differentiation of human preadipocytes to adipocytes Quantitative Real Time PCR (RT-qPCR) First strand cdna was synthesized and RT-qPCR was performed using RT2 first strand kits (Cat#330401) and RT2 qpcr Master Mix (SABioscience, Frederick, MD). Experiments

More information

Supplementary Information

Supplementary Information Supplementary Information Index of Supplementary Materials Supplementary Figure. Distribution of methylation levels, characteristics of cis-meqtls and association plots for meqtls in methylation-related

More information

Autism/ID Xpanded Panel Gene List (~2000)

Autism/ID Xpanded Panel Gene List (~2000) Autism/ID Xpanded Panel Gene List (~2000) Approximately 84% of the genes are covered >99% at 10X and the average coverage of a gene at 10X for this panel is >98%. A2M A2ML1 AAAS AARS AARS2 AASS ABAT ABCA1

More information

Patricia Aoun MD, MPH Professor and Vice-Chair for Clinical Affairs Medical Director, Clinical Laboratories Department of Pathology City of Hope

Patricia Aoun MD, MPH Professor and Vice-Chair for Clinical Affairs Medical Director, Clinical Laboratories Department of Pathology City of Hope Patricia Aoun MD, MPH Professor and Vice-Chair for Clinical Affairs Medical Director, Clinical Laboratories Department of Pathology City of Hope National Medical Center Disclosures I have no disclosures

More information

Outline. Next-Generation Sequencing. The Application of Genomic Medicine in Clinical and Laboratory Practice

Outline. Next-Generation Sequencing. The Application of Genomic Medicine in Clinical and Laboratory Practice Outline The Application of Genomic Medicine in Clinical and Laboratory Practice Jerry Feldman, MD, PhD, FACMG Medical Director, Division of Laboratory Genetics and Molecular Pathology, Detroit Medical

More information

Provide your cancer patients personalized treatment options with ClariFind

Provide your cancer patients personalized treatment options with ClariFind ONCOLOGY ClariFind employs next-generation sequencing (NGS) for comprehensive genomic profiling of a patient s tumor sample to identify potential clinically actionable targets and associated therapies.

More information

Changing the Culture of Cancer Care II. Eric Holland Fred Hutchinson Cancer Research Center University of Washington Seattle

Changing the Culture of Cancer Care II. Eric Holland Fred Hutchinson Cancer Research Center University of Washington Seattle Changing the Culture of Cancer Care II Eric Holland Fred Hutchinson Cancer Research Center University of Washington Seattle Transforming Cancer Therapy Eric Holland Fred Hutchinson Cancer Research Center

More information

The International Association for the Study of Lung Cancer (IASLC) Lung Cancer Staging Project, Data Elements

The International Association for the Study of Lung Cancer (IASLC) Lung Cancer Staging Project, Data Elements Page 1 Contents 1.1. Registration... 2 1.2. Patient Characteristics... 3 1.3. Laboratory Values at Diagnosis... 5 1.4. Lung Cancers with Multiple Lesions... 8 1.5. Primary Tumour Description... 10 1.6.

More information

X-Linked Intellectual Disability (revised January 2019)

X-Linked Intellectual Disability (revised January 2019) X-Linked Intellectual Disability (revised January 2019) Information posted on these pages are intended to complement and update the Atlas of X- Linked Intellectual Disability Syndromes, Edition 2, by Stevenson,

More information

Autism Spectrum Disorder and Itellectual Disability (ASD-ID) Comprehensive Panel Gene List Genes: A2M - ATRX A2M ADAR ALG13 ARHGEF6 A2ML1 ADAT3 ALG2

Autism Spectrum Disorder and Itellectual Disability (ASD-ID) Comprehensive Panel Gene List Genes: A2M - ATRX A2M ADAR ALG13 ARHGEF6 A2ML1 ADAT3 ALG2 Genes: A2M - ATRX A2M ADAR ALG13 ARHGEF6 A2ML1 ADAT3 ALG2 ARHGEF9 AAAS ADCY1 ALG3 ARID1A AARS ADCY3 ALG6 ARID1B AARS2 ADCY5 ALMS1 ARID2 AASS ADD3 ALOX12B ARL13B ABAT ADGRG1 ALOXE3 ARL6 ABCA1 ADGRV1 ALS2

More information

I. New Syndromes and Localizations

I. New Syndromes and Localizations Information posted on this page is intended to complement and update the Atlas of X-Linked Intellectual Disability Syndromes, Edition 2, by R.E. Stevenson, C.E. Schwartz, and R.C. Rogers (Oxford University

More information

Genomic Service List

Genomic Service List Document ID: MBG-C009 Effective Date: 10 Jan 018 Page: 1 of 5 WHOLE GENOME SEQUENCING Human Whole Genome Sequencing 1 HGG-15 Human Whole Genome Sequencing HGG-157 (FASTQ data only) WHOLE EXOME SEQUENCING

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION SUPPLEMENTARY INFORMATION Frampton et al. Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing Supplementary Figure 1A Base substitution detection

More information

Integration of Next-Generation Sequencing into Epilepsy Clinical Care. Michelle Demos University of British Columbia BC Children s Hospital

Integration of Next-Generation Sequencing into Epilepsy Clinical Care. Michelle Demos University of British Columbia BC Children s Hospital Integration of Next-Generation Sequencing into Epilepsy Clinical Care Michelle Demos University of British Columbia BC Children s Hospital No Disclosures Learning Objectives To review: the impact of using

More information

The Genetics of Alcoholism. Robert Hitzemann, Ph.D. Departments of Behavioral Neuroscience & Psychiatry Oregon Health & Science University

The Genetics of Alcoholism. Robert Hitzemann, Ph.D. Departments of Behavioral Neuroscience & Psychiatry Oregon Health & Science University The Genetics of Alcoholism Robert Hitzemann, Ph.D. Departments of Behavioral Neuroscience & Psychiatry Oregon Health & Science University Genetics, Genomics and Alcoholism Robert Hitzemann, Ph.D. Departments

More information

Assessing the Economics of Genomic Medicine. Kenneth Offit, MD MPH Chief, Clinical Genetics Service Memorial Sloan-Kettering Cancer Center

Assessing the Economics of Genomic Medicine. Kenneth Offit, MD MPH Chief, Clinical Genetics Service Memorial Sloan-Kettering Cancer Center Assessing the Economics of Genomic Medicine Kenneth Offit, MD MPH Chief, Clinical Genetics Service Memorial Sloan-Kettering Cancer Center DISCLOSURES No conflicts Patents unenforced Consultancies unpaid

More information

Sample Metrics. Allele Frequency (%) Read Depth Ploidy. Gene CDS Effect Protein Effect. LN Metastasis Tumor Purity Computational Pathology 80% 60%

Sample Metrics. Allele Frequency (%) Read Depth Ploidy. Gene CDS Effect Protein Effect. LN Metastasis Tumor Purity Computational Pathology 80% 60% Supplemental Table 1: Estimated tumor purity, allele frequency, and independent read depth for all gene mutations classified as either potentially pathogenic or VUS in the metatastic and primary tumor

More information

Table e-1: Investigation of 33 patients with early onset epilepsy for KCNT1 mutations.

Table e-1: Investigation of 33 patients with early onset epilepsy for KCNT1 mutations. Table e1: Investigation of 33 patients with early onset epilepsy for KCNT1 mutations. Patient Phenotype Screening Method Diagnostic Karyotype Sanger sequencing NGS Diagnostic Panel WES chromosomal microarray

More information

Why Pathway/Network Analysis?

Why Pathway/Network Analysis? 6/8/16 More Depth on Pathway and Network Analysis Lincoln Stein Why Pathway/Network Analysis? Drama@c data size reduc@on: 1000 s of genes => dozens of pathways. Increase sta@s@cal power by reducing mul@ple

More information

Novel mutation of type 1 insulin-like growth factor receptor (IGF1R) gene in a severe short stature pedigree identified by targeted

Novel mutation of type 1 insulin-like growth factor receptor (IGF1R) gene in a severe short stature pedigree identified by targeted Research Article Novel mutation of type 1 insulin-like growth factor receptor (IGF1R) gene in a severe short stature pedigree identified by targeted next-generation sequencing Running title: Novel mutation

More information

Mutations of Chromatin Structure Regulating Genes in Human Malignancies

Mutations of Chromatin Structure Regulating Genes in Human Malignancies Send Orders for Reprints to reprints@benthamscience.ae Current Protein and Peptide Science, 2016, 17, 411-437 411 Mutations of Chromatin Structure Regulating Genes in Human Malignancies Jian Chen*, Franklin

More information

Clinically Useful Next Generation Sequencing and Molecular Testing in Gliomas MacLean P. Nasrallah, MD PhD

Clinically Useful Next Generation Sequencing and Molecular Testing in Gliomas MacLean P. Nasrallah, MD PhD Clinically Useful Next Generation Sequencing and Molecular Testing in Gliomas MacLean P. Nasrallah, MD PhD Neuropathology Fellow Division of Neuropathology Center for Personalized Diagnosis (CPD) Glial

More information

Whole exome sequencing Gene package Epilepsy version 1,

Whole exome sequencing Gene package Epilepsy version 1, Whole Exome Sequencing Gene package Epilepsy, version 1, 8 4 2015 Technical information After DNA was enriched using Agilent Sureselect Clinical Research Exome (CRE) Capture, samples were run on the Illumina

More information

Syddansk Universitet. Published in: npj Genomic Medicine. DOI: /s Publication date: 2018

Syddansk Universitet. Published in: npj Genomic Medicine. DOI: /s Publication date: 2018 Syddansk Universitet A 360 evaluation Oates, Stephanie; Tang, Shan; Rosch, Richard; Lear, Rosalie; Hughes, Elaine F.; Williams, Ruth E.; Larsen, Line H.G.; Hao, Qin; Dahl, Hans Atli; Møller, Rikke S; Pal,

More information

INVITAE METABOLIC DISORDERS AND NEWBORN SCREENING GENE PANEL TESTS

INVITAE METABOLIC DISORDERS AND NEWBORN SCREENING GENE PANEL TESTS INVITAE METABOLIC DISORDERS AND NEWBORN SCREENING GENE PANEL TESTS A broad menu covering the vast majority of inherited metabolic disorders that are routinely tested as part of state newborn screening

More information

Epilepsie & ernstige mentale retardatie: (nieuwe) genen en genotype-fenotype correlatie

Epilepsie & ernstige mentale retardatie: (nieuwe) genen en genotype-fenotype correlatie Epilepsie & ernstige mentale retardatie: (nieuwe) genen en genotype-fenotype correlatie dr. Hannah Stamberger prof. dr. Peter De Jonghe Neurogenetics group, DMG, VIB http://www.molgen.vib-ua.be Disclosures

More information

# 1 India s Best Selling Cancer Genomics Test Precision treatment for every Cancer Patient Patient Guide

# 1 India s Best Selling Cancer Genomics Test Precision treatment for every Cancer Patient Patient Guide # 1 India s Best Selling Cancer Genomics Test Precision treatment for every Cancer Patient Patient Guide PositiveSelect is India s widely used Cancer Genomics test with every 8 out of 10 patients opting

More information

syndromes associated with brain malformation - dysmorphology Renske Oegema, MD, PhD clinical geneticist UMC Utrecht, NL Milano, 2018

syndromes associated with brain malformation - dysmorphology Renske Oegema, MD, PhD clinical geneticist UMC Utrecht, NL Milano, 2018 syndromes associated with brain malformation - dysmorphology Renske Oegema, MD, PhD clinical geneticist UMC Utrecht, NL Milano, 2018 Miller Dieker syndrome, del 17p13.3 incl LIS1 en YWHAE Postnatal mild

More information

LMM / emerge III Network Reference Sequences October 2016 LMM / emerge III Network Consensus Actionable Gene List *ACMG56 gene

LMM / emerge III Network Reference Sequences October 2016 LMM / emerge III Network Consensus Actionable Gene List *ACMG56 gene LMM / emerge III Network Consensus Actionable Gene List *ACMG56 gene ACTA2* Exon 02-09 NM_001613.2 DSG2* Exon 01-15 NM_001943.3 ACTC1* Exon 01-06 NM_005159.4 DSP* Exon 01-24 NM_004415.2 APC* Exon 01-15

More information

Dr. Sarah Weckhuysen, MD, PhD. Neurogenetics Group, VIB-Department of Molecular Genetics University of Antwerp, Belgium

Dr. Sarah Weckhuysen, MD, PhD. Neurogenetics Group, VIB-Department of Molecular Genetics University of Antwerp, Belgium Dr. Sarah Weckhuysen, MD, PhD Neurogenetics Group, VIB-Department of Molecular Genetics University of Antwerp, Belgium Sarah Weckhuysen No relevant financial relationships with any commercial interests.

More information

Table S1. Demographics of patients and tumor characteristics.

Table S1. Demographics of patients and tumor characteristics. Supplemental Tables for: A Clinical Actionability of Comprehensive Genomic Profiling for Management of Rare or Refractory Cancers Kim Hirshfield et al. Table S1. Demographics of patients and tumor characteristics.

More information

Jennifer Hauenstein Oncology Cytogenetics Emory University Hospital Atlanta, GA

Jennifer Hauenstein Oncology Cytogenetics Emory University Hospital Atlanta, GA Comparison of Genomic Coverage using Affymetrix OncoScan Array and Illumina TruSight Tumor 170 NGS Panel for Detection of Copy Number Abnormalities in Clinical GBM Specimens Jennifer Hauenstein Oncology

More information

Leistungsverzeichnis

Leistungsverzeichnis Leistungsverzeichnis SYNLAB MVZ Humangenetik Mannheim Genetische Beratung / Molekulargenetische Diagnostik / Molekulare Zytogenetik / Abstammungsgutachten und Vaterschaftstest www.zhma.de Akkreditiert

More information

Erratum to: What is new in CDG?

Erratum to: What is new in CDG? J Inherit Metab Dis (2017) 40:621 625 DOI 10.1007/s10545-017-0068-9 ERRATUM Erratum to: What is new in CDG? Jaak Jaeken 1 & Romain Péanne 2 Published online: 26 June 2017 # SSIEM 2017 Erratum to: J Inherit

More information

Supplementary Table 2b. List of spliced oncogenes and tumor suppressors identified in AML patients compared to normal donors

Supplementary Table 2b. List of spliced oncogenes and tumor suppressors identified in AML patients compared to normal donors 1 Supplementary Table 2b. List of spliced oncogenes and tumor suppressors identified in AML patients compared to normal donors Gene Symbol Gene Name / Tumor Suppressors AKT1 v-akt murine thymoma viral

More information

Supplementary Information to

Supplementary Information to Supplementary Information to Exome sequencing to identify de novo mutations in sporadic ALS trios Alessandra Chesi 1,11, Brett T. Staahl 2, Ana Jovicic 1, Julien Couthouis 1, Maria Fasolino 3, Alya R.

More information

Table S2. Functional annotation of the downregulated, differentially expressed genes of Rasless MEFs.

Table S2. Functional annotation of the downregulated, differentially expressed genes of Rasless MEFs. Table S2. Functional annotation of the downregulated, differentially expressed genes of Rasless MEFs. The GeneCodis (Gene Annotation Co-occurrence Discovery) functional annotation tool (http://genecodis.dacya.ucm.es)

More information

The Amazing Brain Webinar Series: Select Topics in Neuroscience and Child Development for the Clinician

The Amazing Brain Webinar Series: Select Topics in Neuroscience and Child Development for the Clinician The Amazing Brain Webinar Series: Select Topics in Neuroscience and Child Development for the Clinician Part VII Recent Advances in the Genetics of Autism Spectrum Disorders Abha R. Gupta, MD, PhD Jointly

More information

RACP Congress 2017 Genetics of Intellectual Disability and Autism: Past Present and Future 9 th May 2017

RACP Congress 2017 Genetics of Intellectual Disability and Autism: Past Present and Future 9 th May 2017 RACP Congress 2017 Genetics of Intellectual Disability and Autism: Past Present and Future 9 th May 2017 Why causation? Explanation for family Prognosis Recurrence risk and reproductive options Guide medical

More information

Enabling Informed Clinical Decisions with Deep Insights. Routine Multi-gene Testing for Inherited Neuromuscular Disorders

Enabling Informed Clinical Decisions with Deep Insights. Routine Multi-gene Testing for Inherited Neuromuscular Disorders Enabling Informed Clinical Decisions with Deep Insights Routine Multi-gene Testing for Inherited Neuromuscular Disorders Introduction Multi-gene Testing for Inherited Neuromuscular Disorders Inherited

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION Supplementary information S1 (table) Examples of genes associated with ASD and their main clinical phenotypes. Genes Observations Chromatin remodelling MECP2 Females with a mutation in the X-linked MECP2

More information

WT-TP53 DLBCL WT-TP53 GCB-DLBCL

WT-TP53 DLBCL WT-TP53 GCB-DLBCL SUPPLEMENTAL TABLES AND FIGURES Supplemental Table S1. Summary of gene expression profiling analysis results listing counts of significant differentially expressed transcripts between defined two groups

More information

Clinical Exomes: Gene List Catalogue (October 2018)

Clinical Exomes: Gene List Catalogue (October 2018) Clinical Exomes: Gene List Catalogue (October 2018) se of phenotype specific gene lists to target analysis improves diagnostic yield. Refer below for the comprehensive catalogue (index and detailed list)

More information

Whole exome sequencing Gene package Epilepsy version 2,

Whole exome sequencing Gene package Epilepsy version 2, Whole Exome Sequencing Gene package Epilepsy, version 2, 1 7 2017 Technical information After DNA was enriched using Agilent Sureselect Clinical Research Exome (CRE) Capture, samples were run on the Illumina

More information

Rebecca Muhle, M.D. Ph.D. Yale Child Study Center Yale University The Autism Center Hospital for Special Care

Rebecca Muhle, M.D. Ph.D. Yale Child Study Center Yale University The Autism Center Hospital for Special Care Genetic Work-Up of Autism Spectrum Disorder in a Clinical Setting Rebecca Muhle, M.D. Ph.D. Yale Child Study Center Yale University The Autism Center Hospital for Special Care Disclosures statement I have

More information

Epi4K. Epi4K Consortium. Epi4K: gene discovery in 4,000 genomes, Epilepsia, 2012 Aug;53(8):

Epi4K. Epi4K Consortium. Epi4K: gene discovery in 4,000 genomes, Epilepsia, 2012 Aug;53(8): Epi4K Epi4K Consortium. Epi4K: gene discovery in 4,000 genomes, Epilepsia, 2012 Aug;53(8):1457-67. Genetics of Epileptic Encephalopathies Infantile Spasms (IS) 1 in 3000 live births and onset between 4-12

More information

Investigation of chromosomal abnormalities and microdeletions in 50 patients with multiple congenital anomalies

Investigation of chromosomal abnormalities and microdeletions in 50 patients with multiple congenital anomalies Investigation of chromosomal abnormalities and microdeletions in 50 patients with multiple congenital anomalies Akbar Mohammadzadeh MD, PhD candidate in Medical Genetics Genetics Research Center University

More information

Inferring the Mammalian Cardiogenic Gene Regulatory Network. Jason Bazil 10/18/13 Cardiac Physiome Workshop 2013

Inferring the Mammalian Cardiogenic Gene Regulatory Network. Jason Bazil 10/18/13 Cardiac Physiome Workshop 2013 Inferring the Mammalian Cardiogenic Gene Regulatory Network Jason Bazil 1/18/13 Cardiac Physiome Workshop 213 Reverse Engineering Gene Regulatory Networks Two main questions need addressed: 1) What s connected

More information

Regulation of eif4 and p70s6k signaling. Chondroitin and dermatan biosynthesis Interferon signaling

Regulation of eif4 and p70s6k signaling. Chondroitin and dermatan biosynthesis Interferon signaling Supplemental Information Table S1: Differentially regulated pathways in cortical versus cerebellar human astrocytes following treatment with PBS or IFN-β Pathway Regulation of eif4 and p70s6k signaling

More information

Utilization of the MiSeq in a clinical lab. Tony Krentz, PhD PreventionGenetics

Utilization of the MiSeq in a clinical lab. Tony Krentz, PhD PreventionGenetics Utilization of the MiSeq in a clinical lab Tony Krentz, PhD PreventionGenetics PreventionGenetics Founded in 2004 in Marshfield, Wisconsin by James Weber ~90 employees Largest test menu in US Vision: Disease

More information

Phone: Address: Address: City State Zip Code City State Zip Code. Phone: Fax: Phone: Fax: Genetic Counselor:

Phone: Address: Address: City State Zip Code City State Zip Code. Phone: Fax: Phone: Fax: Genetic Counselor: MOLECULAR (DNA) TEST REQUISITION FOR CHG LAB USE ONLY: Center for Human Genetics, Inc. Date received: Riverside Technology Center Pedigree #: 840 Memorial Drive, Suite 101 Family name: Cambridge, MA 02139

More information

Supplementary Information

Supplementary Information Supplementary Information Table of Contents Supplementary methods... 2 Figure S1 - Variable DNA yield proportional to bone marrow aspirate cellularity.... 3 Figure S2 - Mutations by clinical ontogeny group....

More information

A genome-wide linkage study of autism spectrum disorder and the broad autism. phenotype in extended pedigrees

A genome-wide linkage study of autism spectrum disorder and the broad autism. phenotype in extended pedigrees A genome-wide linkage study of autism spectrum disorder and the broad autism phenotype in extended pedigrees Short title: Genome-wide linkage in autism extended pedigrees Marc Woodbury-Smith, Andrew D.

More information

Microcephaly Sequencing Panel

Microcephaly Sequencing Panel Microcephaly is typically defined as an occipitofrontal circumference (OFC) of at least 2 standard deviations below the mean. Microcephaly may be congenital, or can be acquired postnatally (1). Microcephaly

More information

Supplementary Information

Supplementary Information 1 Supplementary Information Human TSC2 Null Fibroblast-Like Cells Induce Hair Follicle Neogenesis and Hamartoma Morphogenesis Shaowei Li 1, Rajesh L. Thangapazham 1, Ji-an Wang 1, Sangeetha Rajesh 1, Tzu-Cheg

More information

Phone: Referring Provider: NPI #: Referring Laboratory (if different): Physician signature: Name: Name: Address: Address:

Phone: Referring Provider: NPI #: Referring Laboratory (if different): Physician signature: Name: Name: Address: Address: MOLECULAR (DNA) TEST REQUISITION FOR CHG LAB USE ONLY: Center for Human Genetics, Inc. Date received: Riverside Technology Center Pedigree #: 840 Memorial Drive, Suite 101 Family name: Cambridge, MA 02139

More information